http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2169188-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99c2e4f96a89151d3257b28b1b5d1888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_828c9fbd974a951f52401ccd96827d3b |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-385 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-104 |
| filingDate | 1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b01189524b658a64f79d76db5bb9c66a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499a9f331f8c9f193c7891dfd240a3f8 |
| publicationDate | 2001-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2169188-C2 |
| titleOfInvention | Strain of bacterium pseudomonas aeruginosa 4492 used for making vaccine against fur wild animal pseudomonosis |
| abstract | FIELD: biotechnology, veterinary science. SUBSTANCE: invention relates to production of vaccine preparations against pyocyanic infection in fur wild animals, mainly, in polar foxes and foxes. Strain of bacterium Pseudomonas aeruginosa is deposited in collection of strains that are pathogens of diseases in fur wild animals of museum of bacterial and viral cultures of Science- Research institute of fur farming and rabbit breeding (NIIPZK) named for V. A. Afanasiev and has registration number 449 2 . Strain relates to serovariant 03. Strain is cultured in Marten's broth or synthetic medium at 32 C for 18-20 h at constant shaking. After control of grown culture for toxicogenicity and proteolytic activity bacterial mass is separated and inactivated, aluminum hydroxide is added as an adjuvant and packaged. Invention ensures to prevent the concealed loss in fur wild animals reproduction in farms with pyocyanic infection being independently of serological pattern of pathogen. EFFECT: strain indicated above, enhanced effectiveness of vaccine. |
| priorityDate | 1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.